Cassava Sciences (FRA:PX91) 5-Year EBITDA Growth Rate : -49.00% (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Cassava Sciences 5-Year EBITDA Growth Rate?

Cassava Sciences's EBITDA per Share for the three months ended in Mar. 2024 was €-0.41.

During the past 3 years, the average EBITDA Per Share Growth Rate was -112.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -49.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cassava Sciences was 74.60% per year. The lowest was -133.30% per year. And the median was -4.10% per year.

Competitive Comparison of Cassava Sciences's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Cassava Sciences's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cassava Sciences's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's 5-Year EBITDA Growth Rate falls into.

Cassava Sciences 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cassava Sciences (FRA:PX91) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Cassava Sciences 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cassava Sciences (FRA:PX91) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (FRA:PX91) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SAVA:USA SAVA:Mexico

Address

6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731

Website

https://www.cassavasciences.com

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Cassava Sciences (FRA:PX91) Headlines

No Headlines